Recent Posts
81
C19 Notes Database / Warning of serious brain disorders in people with mild coronavirus symptoms
« Last post by stog on July 08, 2020, 03:52:23 PM »UK neurologists publish details of mildly affected or recovering Covid-19 patients with serious or potentially fatal brain conditions
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned.
Neurologists are on Wednesday publishing details of more than 40 UK Covid-19 patients whose complications ranged from brain inflammation and delirium to nerve damage and stroke. In some cases, the neurological problem was the patient’s first and main symptom.
The cases, published in the journal Brain, revealed a rise in a life-threatening condition called acute disseminated encephalomyelitis (Adem), as the first wave of infections swept through Britain. At UCL’s Institute of Neurology, Adem cases rose from one a month before the pandemic to two or three per week in April and May. One woman, who was 59, died of the complication.
Read more A dozen patients had inflammation of the central nervous system, 10 had brain disease with delirium or psychosis, eight had strokes and a further eight had peripheral nerve problems, mostly diagnosed as Guillain-Barré syndrome, an immune reaction that attacks the nerves and causes paralysis. It is fatal in 5% of cases.
“We’re seeing things in the way Covid-19 affects the brain that we haven’t seen before with other viruses,” said Michael Zandi, a senior author on the study and a consultant at the institute and University College London Hospitals NHS foundation trust.
“What we’ve seen with some of these Adem patients, and in other patients, is you can have severe neurology, you can be quite sick, but actually have trivial lung disease,” he added.
https://www.theguardian.com/world/2020/jul/08/warning-of-serious-brain-disorders-in-people-with-mild-covid-symptoms
Doctors may be missing signs of serious and potentially fatal brain disorders triggered by coronavirus, as they emerge in mildly affected or recovering patients, scientists have warned.
Neurologists are on Wednesday publishing details of more than 40 UK Covid-19 patients whose complications ranged from brain inflammation and delirium to nerve damage and stroke. In some cases, the neurological problem was the patient’s first and main symptom.
The cases, published in the journal Brain, revealed a rise in a life-threatening condition called acute disseminated encephalomyelitis (Adem), as the first wave of infections swept through Britain. At UCL’s Institute of Neurology, Adem cases rose from one a month before the pandemic to two or three per week in April and May. One woman, who was 59, died of the complication.
Read more A dozen patients had inflammation of the central nervous system, 10 had brain disease with delirium or psychosis, eight had strokes and a further eight had peripheral nerve problems, mostly diagnosed as Guillain-Barré syndrome, an immune reaction that attacks the nerves and causes paralysis. It is fatal in 5% of cases.“We’re seeing things in the way Covid-19 affects the brain that we haven’t seen before with other viruses,” said Michael Zandi, a senior author on the study and a consultant at the institute and University College London Hospitals NHS foundation trust.
“What we’ve seen with some of these Adem patients, and in other patients, is you can have severe neurology, you can be quite sick, but actually have trivial lung disease,” he added.
https://www.theguardian.com/world/2020/jul/08/warning-of-serious-brain-disorders-in-people-with-mild-covid-symptoms
82
C19 Notes Database / How long does COVID-19 last
« Last post by stog on July 06, 2020, 03:06:51 PM »How long does COVID-19 last?
Our data shows one in ten are sick for three weeks or more.
It’s commonly believed that COVID-19 is a short-term illness caused by infection with the novel SARS-CoV-2 coronavirus, and most health sources suggest that people will recover within two weeks or so.
But it’s becoming increasingly clear that this isn’t the case for everyone infected with coronavirus. Some people have reported symptoms for three weeks or more, while others have been suffering for months.
We look at what the data from the COVID Symptom Study app is telling us about the number of people living with COVID-19 over the longer term, the symptoms they are experiencing, and whether they are still infectious.
(The COVID-19 Symptom Study app has been developed by health science company ZOE and it is endorsed by the Welsh Government, NHS Wales, the Scottish Government and NHS Scotland. 3,964,955 participants have downloaded the app and are using it to regularly report on their health, making it the largest public science project of its kind anywhere in the world. App data is being analysed in collaboration with King's College London researchers.)
https://covid.joinzoe.com/post/covid-long-term?
Our data shows one in ten are sick for three weeks or more.
It’s commonly believed that COVID-19 is a short-term illness caused by infection with the novel SARS-CoV-2 coronavirus, and most health sources suggest that people will recover within two weeks or so.
But it’s becoming increasingly clear that this isn’t the case for everyone infected with coronavirus. Some people have reported symptoms for three weeks or more, while others have been suffering for months.
We look at what the data from the COVID Symptom Study app is telling us about the number of people living with COVID-19 over the longer term, the symptoms they are experiencing, and whether they are still infectious.
(The COVID-19 Symptom Study app has been developed by health science company ZOE and it is endorsed by the Welsh Government, NHS Wales, the Scottish Government and NHS Scotland. 3,964,955 participants have downloaded the app and are using it to regularly report on their health, making it the largest public science project of its kind anywhere in the world. App data is being analysed in collaboration with King's College London researchers.)
https://covid.joinzoe.com/post/covid-long-term?
83
C19 Notes Database / COVID-19 Symptom Study app
« Last post by stog on July 06, 2020, 03:01:53 PM »The COVID-19 Symptom Study app has been developed by health science company ZOE and it is endorsed by the Welsh Government, NHS Wales, the Scottish Government and NHS Scotland. 3,964,955 participants have downloaded the app and are using it to regularly report on their health, making it the largest public science project of its kind anywhere in the world. App data is being analysed in collaboration with King's College London researchers.
https://covid.joinzoe.com/data
https://covid.joinzoe.com/data
84
C19 Notes Database / pediatric multisystem inflammatory syndrome (MIS) may experience neurologic symp
« Last post by stog on July 04, 2020, 03:17:09 PM »Children with COVID-19-related pediatric multisystem inflammatory syndrome (MIS) may experience neurologic symptoms that involve the central nervous system and the peripheral nervous system, new research suggests.
In a case-series study of 27 children with COVID-19 MIS at a hospital in London, United Kingdom, four presented with new-onset symptoms that included headache, brainstem and cerebellar signs, encephalopathy, muscle weakness, and reduced reflexes.
After the patients were admitted to an intensive care unit, MRI scans showed splenium signal changes in all four patients. In addition, a "mild excess of slow activity" was found in the three children who underwent electroencephalography, and mild myopathic and neuropathic changes were found in the three who underwent nerve conduction measures and electromyography.
By end of study, all four showed neurologic improvement, and two had made a full recovery.
"Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19," write the investigators, led by Omar Abdel-Mannan, MD, Department of Neurology, Great Ormond Street Hospital for Children, London.
The findings were published online July 1 in JAMA Neurology.
https://www.medscape.com/viewarticle/933311
In a case-series study of 27 children with COVID-19 MIS at a hospital in London, United Kingdom, four presented with new-onset symptoms that included headache, brainstem and cerebellar signs, encephalopathy, muscle weakness, and reduced reflexes.
After the patients were admitted to an intensive care unit, MRI scans showed splenium signal changes in all four patients. In addition, a "mild excess of slow activity" was found in the three children who underwent electroencephalography, and mild myopathic and neuropathic changes were found in the three who underwent nerve conduction measures and electromyography.
By end of study, all four showed neurologic improvement, and two had made a full recovery.
"Additional research is needed to assess the association of neurological symptoms with immune-mediated changes among children with COVID-19," write the investigators, led by Omar Abdel-Mannan, MD, Department of Neurology, Great Ormond Street Hospital for Children, London.
The findings were published online July 1 in JAMA Neurology.
https://www.medscape.com/viewarticle/933311
85
C19 Notes Database / multisystem inflammatory syndrome in children (MIS-C)
« Last post by stog on July 04, 2020, 03:09:28 PM »July 2 2020
New data from active surveillance of the severe inflammatory condition associated with COVID-19 in previously healthy children provide further insight into the prevalence and course of the rare syndrome, but experts are concerned that current diagnostic criteria may not capture the true scope of the problem.
In separate reports published online June 29 in the New England Journal of Medicine, researchers from the New York State Department of Health and the Centers for Disease Control and Prevention (CDC) describe the epidemiology and clinical features of multisystem inflammatory syndrome in children (MIS-C) on the basis of information derived from targeted surveillance programs in New York State and across the country.
All children presented with fever or chills, and most had tachycardia (97%) and gastrointestinal symptoms (80%). Rash (60%), conjunctival injection (56%), hypotension (32%), and mucosal changes (27%) were reported. Among all of the children, levels of inflammatory markers were elevated, including levels of C-reactive protein (100%), d-dimer (91%), and troponin (71%). More than one third of the patients (36%) were diagnosed with myocarditis, and an additional 16% had clinical myocarditis.
Of the full cohort, 80% of the children required intensive care, 62% received vasopressor support, and two children died.
The high prevalence of cardiac dysfunction or depression, coagulopathy, gastrointestinal symptoms, mild respiratory symptoms, and indications for supplemental oxygen in patients with MIS-C stands in contrast to the clinical picture observed in most acute cases of COVID-19 in hospitalized children, the authors write.
"Although most children have mild or no illness from SARS-CoV-2 infection, MIS-C may follow Covid-19 or asymptomatic SARS-CoV-2 infection. Recognition of the syndrome and early identification of children with MIS-C, including early monitoring of blood pressure and electrocardiographic and echocardiographic evaluation, could inform appropriate supportive care and other potential therapeutic options," they continue.
https://www.medscape.com/viewarticle/933303
New data from active surveillance of the severe inflammatory condition associated with COVID-19 in previously healthy children provide further insight into the prevalence and course of the rare syndrome, but experts are concerned that current diagnostic criteria may not capture the true scope of the problem.
In separate reports published online June 29 in the New England Journal of Medicine, researchers from the New York State Department of Health and the Centers for Disease Control and Prevention (CDC) describe the epidemiology and clinical features of multisystem inflammatory syndrome in children (MIS-C) on the basis of information derived from targeted surveillance programs in New York State and across the country.
All children presented with fever or chills, and most had tachycardia (97%) and gastrointestinal symptoms (80%). Rash (60%), conjunctival injection (56%), hypotension (32%), and mucosal changes (27%) were reported. Among all of the children, levels of inflammatory markers were elevated, including levels of C-reactive protein (100%), d-dimer (91%), and troponin (71%). More than one third of the patients (36%) were diagnosed with myocarditis, and an additional 16% had clinical myocarditis.
Of the full cohort, 80% of the children required intensive care, 62% received vasopressor support, and two children died.
The high prevalence of cardiac dysfunction or depression, coagulopathy, gastrointestinal symptoms, mild respiratory symptoms, and indications for supplemental oxygen in patients with MIS-C stands in contrast to the clinical picture observed in most acute cases of COVID-19 in hospitalized children, the authors write.
"Although most children have mild or no illness from SARS-CoV-2 infection, MIS-C may follow Covid-19 or asymptomatic SARS-CoV-2 infection. Recognition of the syndrome and early identification of children with MIS-C, including early monitoring of blood pressure and electrocardiographic and echocardiographic evaluation, could inform appropriate supportive care and other potential therapeutic options," they continue.
https://www.medscape.com/viewarticle/933303
86
C19 Notes Database / Covid compliance checklist stickers on a pdf to add to records
« Last post by stog on July 02, 2020, 02:24:22 PM »some Covid compliance checklist stickers on a pdf
designed by an Osteopath to stick on Patient records, but could be adapted for use in other areas
COVID
Prescreening complete
No change since screening
Temp on arrival
Risks explained and understood PPEwornM A G V
Room cleaned before
Room cleaned after
No COVID symptoms during appt I have no symptoms/contact with
designed by an Osteopath to stick on Patient records, but could be adapted for use in other areas
COVID
Prescreening complete
No change since screening
Temp on arrival
Risks explained and understood PPEwornM A G V
Room cleaned before
Room cleaned after
No COVID symptoms during appt I have no symptoms/contact with
87
C19 Notes Database / guides for shopping, takeaway, re-opening salons
« Last post by stog on July 02, 2020, 02:20:03 PM »A quick guide to safe shopping during the coronavirus (COVID-19) pandemic
Our quick shopping guide will help you to stay safe and protect others when shopping for essentials.
COVID-19 Social distancing. 2 metre (6 feet)
COVID-19 signage: for businesses or enforcement officers
Limiting the number of customers entering the shop
Maintain 2m distance when queuing outside and in the shop
Keep a distance of 2m at all times
Food delivery and takeaway guidance
A guide for EHPs to share with local food businesses who want to provide temporary food delivery and/or takeaway services.
Food delivery and takeaway guidance (English)
Food delivery and takeaway guidance (Welsh)
How to hand wash
How to hand wash video
This handwashing procedure replicates the recommendations from the World Health Organisation, the NHS and Public Health England.
Washing hands with water
Legionnaires’ disease: lockdown risks and reopening safely
Our guidance document provides essential advice and information on the steps needed to mitigate the dangers of Legionella.
Legionnaires’ disease: lockdown risks and reopening safely (English)
Legionnaires’ disease: lockdown risks and reopening safely (Welsh)
Looking after your mental health and wellbeing during the coronavirus (COVID-19) pandemic
A guide for EHPs on how to look after your mental health and wellbeing.
Reopening salons and spas following lockdown: reducing risks of COVID-19 and other considerations
A guide to assist salons and spas as they prepare to reopen once lockdown restrictions are lifted.
https://www.cieh.org/policy/coronavirus-covid-19/resources/
Our quick shopping guide will help you to stay safe and protect others when shopping for essentials.
COVID-19 Social distancing. 2 metre (6 feet)
COVID-19 signage: for businesses or enforcement officers
Limiting the number of customers entering the shop
Maintain 2m distance when queuing outside and in the shop
Keep a distance of 2m at all times
Food delivery and takeaway guidance
A guide for EHPs to share with local food businesses who want to provide temporary food delivery and/or takeaway services.
Food delivery and takeaway guidance (English)
Food delivery and takeaway guidance (Welsh)
How to hand wash
How to hand wash video
This handwashing procedure replicates the recommendations from the World Health Organisation, the NHS and Public Health England.
Washing hands with water
Legionnaires’ disease: lockdown risks and reopening safely
Our guidance document provides essential advice and information on the steps needed to mitigate the dangers of Legionella.
Legionnaires’ disease: lockdown risks and reopening safely (English)
Legionnaires’ disease: lockdown risks and reopening safely (Welsh)
Looking after your mental health and wellbeing during the coronavirus (COVID-19) pandemic
A guide for EHPs on how to look after your mental health and wellbeing.
Reopening salons and spas following lockdown: reducing risks of COVID-19 and other considerations
A guide to assist salons and spas as they prepare to reopen once lockdown restrictions are lifted.
https://www.cieh.org/policy/coronavirus-covid-19/resources/
88
C19 Notes Database / UK Environmental Health Practitioners info portal
« Last post by stog on July 02, 2020, 01:36:10 PM »Environmental Health Practitioners are uniquely placed to help deal with the crisis caused by the coronavirus (COVID-19) pandemic. To support them and the wider environmental health profession during this challenging period, this section compiles all of our news, blogs and guidance on the subject.
https://www.cieh.org/policy/coronavirus-covid-19/
https://www.cieh.org/policy/coronavirus-covid-19/
89
C19 Notes Database / USA Rt Number by state
« Last post by stog on July 01, 2020, 04:17:08 PM »These are up-to-date values for Rt, in the USA by State --updated regularly
Rt is a key measure of how fast the virus is growing. It’s the average number of people who become infected by an infectious person. If Rt is above 1.0, the virus will spread quickly. When Rt is below 1.0, the virus will stop spreading
https://rt.live/
Rt is a key measure of how fast the virus is growing. It’s the average number of people who become infected by an infectious person. If Rt is above 1.0, the virus will spread quickly. When Rt is below 1.0, the virus will stop spreading
https://rt.live/
90
C19 Notes Database / UK Rt Number
« Last post by stog on July 01, 2020, 04:14:14 PM »for uk Rt nowcast and forecast
Real-time tracking of an epidemic, as data accumulate over time, is an essential component of a public health response to a new outbreak. A team of statistical modellers at the MRC Biostatistics Unit (BSU), University of Cambridge, are working to provide regular now-casts and forecasts of COVID-19 infections and deaths. This information feeds directly to the SAGE sub-group, Scientific Pandemic Influenza sub-group on Modelling (SPI-M), and to regional Public Health England (PHE) teams.
https://www.mrc-bsu.cam.ac.uk/now-casting/
Real-time tracking of an epidemic, as data accumulate over time, is an essential component of a public health response to a new outbreak. A team of statistical modellers at the MRC Biostatistics Unit (BSU), University of Cambridge, are working to provide regular now-casts and forecasts of COVID-19 infections and deaths. This information feeds directly to the SAGE sub-group, Scientific Pandemic Influenza sub-group on Modelling (SPI-M), and to regional Public Health England (PHE) teams.
- Model and report changes Our real-time model has been further updated to allow higher susceptibility to infection in the over-75s. The modelling focusses on regional data and we no longer report an estimate of R[size=70.7%]t[/size] for England. This is better provided through the modelling consensus statement supplied by SPI-M and SAGE.
Updated findings- We estimate that across England, infections are down to 3,000 (1,500–5,800, 95% credible interval) new infections arising each day
- We predict that the number of deaths each day is likely to fall to between 35 and 70 by the middle of July.
- We estimate that it is very likely that R[size=70.7%]t[/size]
- is below 1 in each region of England.
- The Midlands has the highest probability (15%) that R[size=70.7%]t[/size]
- is above 1 and a central estimate for R[size=70.7%]t[/size]
- of 0.89. However, the numbers of new infections occurring in this region on a daily basis is relatively low.
- The data used are only weakly informative on R[size=70.7%]t[/size]
- over the last two weeks. Therefore, the now-cast for current incidence and the forecast of deaths are quite uncertain.
https://www.mrc-bsu.cam.ac.uk/now-casting/